Observations on the Cell Biology of Tissue Factor in Endothelial Cells

Summary

Human umbilical vein endothelial cells (HUVEC) are inducible for tissue factor (TF) activity in culture. Based on experiments using ECGF (4–20 µg/ml) with heparin (90 µg/ml), we obtained the followingresults: 1) In confluent HUVEC cultures, ECGF had essentially no influence on the levels of inducible TF. 2) In growing HUVEC cultures, ECGF reduced the TF response shortly after seeding but full response was regained when cells were kept confluent for 2–3 days. 3) Although secondary cultures responded best to TF induction in the absence of ECGF, the response was essentially equal over at least 8 passages in the prcgcncc of ECGF 1) Of total cellular TF induced in HUVEC, about 25% was available on the surface, and less than 4% was released with theshed plasma membrane vesicles. The proportion of total TF a>ctivity available on the surface of mtact cells wasnot influenced by the presence of ECGF 5) T½, for the decay of TF activity induced was 8.3—9.5 h, whereas in HUVEC when protein synthesis was blocked afterIF induction a T_½ of about 30 h was found.

• References

• 1 Lyberg T, Gaidai KS, Prydz H. Synthesis of thromboplastin protein in endothelial cells. 2nd International Symposium on The Biology of Vascular Endothelial Cells. Cambridge, U.K. 1981; 47
• 2 Bjørklid E, Storm E, Prydz H. The protein component of human brain thromboplastin. Biochem Biophys Res Comm 1973; 55: 969-976
• 3 Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII. Proc Natl Acad Sci 1977; 74: 5260-5264
• 4 Stern D, Nawroth P, Handley D, Kisiel W. An endothelial cell-dependent pathway of coagulation. Proc Natl Acad Sci 1985; 88: 2523-2527
• 5 Jaffe EA, Nachman RL, Becher CG, Minick CR. Culture of human endothelial cell derived from umbilical veins. J Clin Invest 1973; 52: 2745-2756
• 6 Thornton SC, Mueller SN, Levine EM. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 1983; 222: 623-625
• 7 Hjort PF. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scand J Clin Invest 1957 9. suppl 27
• 8 Hvatum M, Prydz H. Studies on tissue thromboplastin. Solubilization with sodium deoxycholate. Biochem Biophys Acta 1966; 130: 92-101
• 9 Prydz H. The production in rabbits of an antiserum against Factor VII. Scand J Clin Lab Invest 1965; 17: 66-72
• 10 Bjørklid E, Storm E. Purification and some properties of the protein component of tissue thromboplastin from human brain. Biochem J 1977; 165: 89
• 11 Lyberg T, Gaidai KS, Evensen SA, Prydz H. Cellular cooperation in endothelial cell thromboplastin synthesis. Br J Haematol 1983; 53: 85-95
• 12 Markwell MA K, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87: 206-210
• 13 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol Chem 1951; 193: 265-275
• 14 Almus FE, Rao LV M, Rapaport SI. Decreased inducibility of tissue factor activity on human umbilical vein endothelial cells cultured with endothelial cells growth factor and heparin. Thromb Res 1988; 50: 339-344
• 15 Gospodarowicz D, Brown KD, Birdwell CR, Zetter BR. Control of proliferation of human vascular endothelial cells: Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth tactor and thrombin. J Cell Biol 1978; 77: 774-788
• 16 Weksler BB, Ley CW, Jaffe EA. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin and the tonophore A23187. J Clin Invest 1978; 62: 923-930
• 17 Maciag T, Cerundolo X, Illsley S, Kelley PR, Forand R. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci USA 1979; 76: 5674-5680
• 18 Ristimaki A, Ylikorkala O, Perheentupa J, Viinikka L. Epidermal growth factor stimulates prostacyclin production by cultured human vascular endothelial cells. TDH 1988; 59: 248-250
• 19 Konkle BA, Ginsburg D. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression. J Clin Invest 1988; 82: 579-585
• 20 Nemerson Y, Bach R. Tissue factor revisited. Prog Thromb Hemostas 1982; 6: 237-262
• 21 Hetland O, Brovold A-B, Holme R, Gaudernack G, Prydz H. Thromboplastin (tissue factor) in plasma membranes of human monocytes. Biochem J 1985; 228: 735-743
• 22 Bona R, Lee E, Rickies F. Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles. Thromb Res 1987; 48: 487-500
• 23 Dvorak HF, Vandewater L, Blitzer AM, Dvorak AM, Anderson D, Harvey VS, Bach R, Davis GL, Dewolf W, Carvalho AC A. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 1983; 43: 4334-4342
• 24 Grimstad IA, Prydz H. Thromboplastin release, but not content, correlates with spontaneous metastasis of cancer cells. Int J Cancer 1988; 41: 427-431
• 25 Lyberg T. Studies on the Cell Biology of Thromboplastin Ph.D Thesis. University of Oslo; Oslo: 1984
• 26 Drake TA, Ruf W, Morrissey JH, Edgington TS. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimu-lated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol 1989; 109: 389-395